Related content

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

By Fountzilas George   Pectasides Dimitrios   Christodoulou Christos   Timotheadou Eleni   Economopoulos Theofanis   Papakostas Pavlos   Papadimitriou Christos   Gogas Helen   Efstratiou Ioannis   Skarlos Dimosthenis  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 479-488

Humana Press, Inc

Access to resources Recommend Favorite

High-dose Chemotherapy of Breast Cancer: Current Status and Developmental Strategies

By Crown J.   Raptis G.   Hamilton N.   Fennelly D.   Vahdat L.   Norton L.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 809-811

Elsevier

Access to resources Recommend Favorite

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

By Lalisang R.   Erdkamp F.   Rodenburg C.   Knibbeler-van Rossum C.   Nortier J.   Bochove A.   Slee P.   Voest E.   Wils J.   Wals J.   Loosveld O.   Smals A.   Blijham G.   Tjan-Heijnen V.   Schouten H.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 437-445

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

By Kostopoulos Ioannis   Arapantoni-Dadioti Petroula   Gogas Helen   Papadopoulos Savvas   Malamou-Mitsi Vasiliki   Scopa Chrisoula   Markaki Sofia   Karagianni Evangelia   Kyriakou Vasiliki   Margariti Anastasia   Kyrkou Elisavet   Pavlakis Kitty   Zaramboukas Thomas   Skordalaki Anna   Bourli Antonia   Markopoulos Christos   Pectasides Dimitrios   Dimopoulos Meletios   Skarlos Dimosthenis   Fountzilas George  

Breast Cancer Research and Treatment, Vol. 96, Iss. 3, 2006-04 ,pp. : 251-261

Springer Publishing Company

Access to resources Recommend Favorite

Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study

By Kümmel Sherko   Thomas Anke   Paepke Stefan   Schwarz Marion   Heinrich Georg   Wetzel Andrea   Elling Dirk   Kohls Andreas   Lichtenegger Werner   Blohmer Jens-Uwe  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 248-254

Informa Healthcare

Access to resources Recommend Favorite